Answer
It alerts healthcare professionals to the risk of immune-related reactions and provides information that can support rapid assessment, including after treatment has stopped.
Sources for this answer
- KEYTRUDA 25 mg/mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.